Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1322028.RAfrDsdMW1DxBsBILxbRy8tDpTZrDCvaZfWIYvHyk4yB0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1322028.RAfrDsdMW1DxBsBILxbRy8tDpTZrDCvaZfWIYvHyk4yB0130_assertion type Assertion NP1322028.RAfrDsdMW1DxBsBILxbRy8tDpTZrDCvaZfWIYvHyk4yB0130_head.
- NP1322028.RAfrDsdMW1DxBsBILxbRy8tDpTZrDCvaZfWIYvHyk4yB0130_assertion description "[Minimal residual disease status was investigated in three patients in continuous complete remission (CCR) after a median follow-up of 44 months; at least one sample from each subject was found positive for the AML1-ETO transcript suggesting a long-term persistence of t(8;21) leukaemic cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1322028.RAfrDsdMW1DxBsBILxbRy8tDpTZrDCvaZfWIYvHyk4yB0130_provenance.
- NP1322028.RAfrDsdMW1DxBsBILxbRy8tDpTZrDCvaZfWIYvHyk4yB0130_assertion evidence source_evidence_literature NP1322028.RAfrDsdMW1DxBsBILxbRy8tDpTZrDCvaZfWIYvHyk4yB0130_provenance.
- NP1322028.RAfrDsdMW1DxBsBILxbRy8tDpTZrDCvaZfWIYvHyk4yB0130_assertion SIO_000772 7794758 NP1322028.RAfrDsdMW1DxBsBILxbRy8tDpTZrDCvaZfWIYvHyk4yB0130_provenance.
- NP1322028.RAfrDsdMW1DxBsBILxbRy8tDpTZrDCvaZfWIYvHyk4yB0130_assertion wasDerivedFrom befree-2016 NP1322028.RAfrDsdMW1DxBsBILxbRy8tDpTZrDCvaZfWIYvHyk4yB0130_provenance.
- NP1322028.RAfrDsdMW1DxBsBILxbRy8tDpTZrDCvaZfWIYvHyk4yB0130_assertion wasGeneratedBy ECO_0000203 NP1322028.RAfrDsdMW1DxBsBILxbRy8tDpTZrDCvaZfWIYvHyk4yB0130_provenance.